• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 15, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Immune defense without collateral damage

Bioengineer.org by Bioengineer.org
January 20, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: (Image: University of Basel, Biozentrum)

Researchers from the University of Basel in Switzerland have clarified the role of the enzyme MPO. In fighting infections, this enzyme, which gives pus its greenish color, produces a highly aggressive acid that can kill pathogens without damaging the surrounding tissue. The findings, published in the current issue of Nature Microbiology, may provide new approaches for immunity strengthening therapies.

In the human body's fight against bacterial pathogens, white blood cells are in the front line. They identify and ingest the invaders, and render them harmless using highly toxic substances. It is important that these substances only destroy bacteria but cause as little collateral damage as possible to the surrounding tissue.

The research groups headed by Prof. Dirk Bumann from the Biozentrum and Dr. Nina Khanna from the Department of Biomedicine at the University and the University Hospital Basel discovered how white blood cells solve this difficult task. The enzyme myeloperoxidase (MPO) attaches directly to the surface of the bacterium where it produces an extremely aggressive acid. The acid reacts instantly in the immediate environment, burning a hole into the bacterial cell envelope which kills the bacterium. In combating bacterial infections, the enzyme acts like a sniper: Equipped with highly explosive ammunition, it targets extremely precisely, without causing collateral damage to their surroundings.

The function of MPO – the greenish color in pus

White blood cells fight bacterial invaders by producing hydrogen peroxide – a toxic substance, which is generally known for its use in bleaching hair. The enzyme MPO then converts hydrogen peroxide into hypochlorous acid. This acid, which is highly aggressive, immediately reacts on the surface of the bacteria and kills the invader. "Bacteria are helpless against this acid bomb," explains Dirk Bumann. "As hypochloric acid is so highly reactive, the bomb reacts immediately with the closest biomolecules. It is ignited locally and does not spread to the wider surroundings. The bacteria die and the surrounding tissue is spared." These findings enabled the research team to elucidate the precise function of the enzyme MPO, which is responsible for the greenish color seen in pus.

Long-term effects of collateral damage have not been sufficiently investigated

In their study, the researchers also investigated cells from humans who lack the enzyme MPO due to a genetic defect. This defect affects around one in 5000 people, making it quite rare. In these individuals, the hydrogen peroxide is not converted into hypochlorous acid and accumulates until it leaks out into the blood cells as well as the surrounding tissue. "The bacteria are still killed even without MPO. However, not only the bacteria but also the blood cells and their surroundings are damaged," explains Bumann. "The collateral damage of blood cells and tissues without MPO may cause long-term consequences such as accelerated aging and cancer, but this has not yet been systematically investigated," adds Nina Khanna.

MPO – an enzyme with two faces

"As we are confronted by fewer infections today than in the past when MPO evolved, the collateral damage issue and its control by MPO might play less important roles," says Khanna. On the other hand, it may be possible to develop new treatment strategies to fight bacterial infections, which support the immune response by strengthening the MPO mechanism. "Currently, only drugs that do the opposite and inhibit MPO are being developed. The reason is that MPO can have negative effects in the case of heart disease," points out Dirk Bumann. However, if such MPO inhibitors were used broadly, patients with infections might suffer.

###

Original source

Nura Schürmann, Pascal Forrer, Olivier Casse, Jiagui Li, Boas Felmy, Anne-Valérie Burgener, Nikolaus Ehrenfeuchter, Wolf-Dietrich Hardt, Mike Recher, Christoph Hess, Astrid Tschan-Plessl, Nina Khanna, Dirk Bumann Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage

Nature Microbiology (2017), doi: 10.1038/nmicrobiol.2016.268

Further information

Prof. Dr. Dirk Bumann, University of Basel, Biozentrum, Tel. +41 61 207 23 82, Email: [email protected]

Heike Sacher, University of Basel, Biozentrum, Communications, Tel. +41 61 207 14 49, Email: [email protected]

Media Contact

Heike Sacher
[email protected]
41-612-071-449
@UniBasel_en

http://www.unibas.ch/

Share12Tweet8Share2ShareShareShare2

Related Posts

Exploring Immunometabolism’s Role in Heart Failure

October 15, 2025
Revolutionary Graph Neural Networks Predict Molecular Properties

Revolutionary Graph Neural Networks Predict Molecular Properties

October 15, 2025

Emotional Fatigue: Nurses Battling Burnout in Ghana

October 15, 2025

Mapping Lymph Node Metastasis in Lung Adenocarcinoma

October 15, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1244 shares
    Share 497 Tweet 311
  • New Study Reveals the Science Behind Exercise and Weight Loss

    105 shares
    Share 42 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    101 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    92 shares
    Share 37 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Immunometabolism’s Role in Heart Failure

Revolutionary Graph Neural Networks Predict Molecular Properties

Emotional Fatigue: Nurses Battling Burnout in Ghana

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.